D
Daxor Corporation DXR
$7.77 -$0.03-0.39% NASDAQ
Recommendation
Prev Close
$7.77
Volume
27
Avg Vol (90D)
6,909
Market Cap
$38.34M
Dividend & Yield
--
52-Week Range
$6.55 - $10.00
P/E (TTM)
76.03
EPS (TTM)
$0.1022
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant ...
4/22/2025 - GuruFocus
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
4/22/2025 - Globe Newswire
Daxor (DXR) to Exhibit at MedAxiom CV Transforum Spring'25 Conference DXR Stock News
4/17/2025 - GuruFocus
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular ...
4/17/2025 - GuruFocus
Daxor to showcase blood volume analysis at Cardiovascular Transforum conference
4/17/2025 - The Fly
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
4/17/2025 - Globe Newswire
Daxor (DXR) Unveils Promising Heart Failure Study Results at ACC Conference DXR Stock News
4/15/2025 - GuruFocus
Daxor announces new data at ACC on blood volume analysis
4/15/2025 - The Fly
New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2. ...
4/15/2025 - GuruFocus
New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
4/15/2025 - Globe Newswire
Daxor (DXR) Submits Next-Gen Blood Analyzer to FDA for Approval DXR Stock News
4/10/2025 - GuruFocus
Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
4/10/2025 - GuruFocus
Daxor announces submission of Daxor BVA to FDA
4/10/2025 - TipRanks Financial Blog
Daxor announces submission of Daxor BVA to FDA
4/10/2025 - The Fly
Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
4/10/2025 - Globe Newswire
Michael Richard Feldschuh Purchases 2,063 Shares of Daxor Co. (NASDAQ:DXR) Stock
4/10/2025 - Ticker Report
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at ...
4/2/2025 - GuruFocus
Daxor announces new data from Duke University on BVA at ACC
4/2/2025 - The Fly
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology's 74th Annual Scientific Session and Expo
4/2/2025 - Globe Newswire
Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey ...
3/28/2025 - GuruFocus
Daxor expands blood volume analysis technology across three networks
3/28/2025 - The Fly
Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks
3/28/2025 - Globe Newswire
Ascendiant Capital Markets Boosts Daxor (NASDAQ:DXR) Price Target to $25.00
3/20/2025 - Ticker Report
Daxor Co. (NASDAQ:DXR) CEO Buys $25,804.80 in Stock
3/12/2025 - MarketBeat
Daxor Co. (NASDAQ:DXR) CEO Buys $25,804.80 in Stock
3/12/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
$119.80K
EBITDA (TTM)
--
EBIT (TTM)
-$1.44M
Net Income (TTM)
$536.40K
Balance Sheet
Total Assets (Q)
$36.63M
Total Debt (Q)
$730.00K
Total Liabilities (Q)
$840.30K
Book Value Per Share (Q)
$7.25
Cash Flow
Cash from Operations (TTM)
$25.60K
Cash from Investing (TTM)
--
Cash from Financing (TTM)
-$25.60K
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 25 and 29 (est)
Price History
Loading...
Beta
-0.16
7-Day Total Return
3.79%
30-Day Total Return
-4.78%
60-Day Total Return
-1.76%
90-Day Total Return
-7.50%
Year to Date Total Return
2.91%
1-Year Total Return
-19.48%
2-Year Total Return
-29.49%
3-Year Total Return
-30.28%
5-Year Total Return
-49.90%
52-week Low
Feb 11, 2025 - $6.55
52-week High
Dec 02, 2024 - $10.00
Valuation
Market Cap
$38.34M - Nano Cap
Enterprise Value
$39.07M
Price/Sales (TTM)
321.07
Price/Book (Q)
1.07
Dividends and Shares
Shares Outstanding
4.93M
Dividend Per Share (Most Recent)
$0.03
Dividend Per Share (TTM)
--
Corporate Info
Website
www.daxor.com
Phone Number
Address
109 Meco Lane
Oak Ridge, TN 37830
Country
United States
Year Founded
1971
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a... more
NASDAQ 04/23/2025 9:30AM Eastern Quotes delayed